Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial

Alice Bonneville-Levard; Didier Frappaz; Olivier Trédan; Emilie Lavergne; Véronique Corset; Vincent Agrapart; Sylvie Chabaud; Daniel Pissaloux; Qing Wang; Valéry Attignon; Stéphanie Cartalat; François Ducray; Laure Thomas-Maisonneuve; Jérôme Honnorat; David Meyronet; Luc Taillandier; Marie Blonski; Alain Viari; Christian Baudet; Emilie Sohier; Sylvie Lantuéjoul; Sandrine Paindavoine; Isabelle Treilleux; Christine Rodriguez; David Pérol; Jean Yves Blay

doi:10.1007/s12032-021-01536-4

Related publications

Article2020

Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial

Patrick Arnaud‐Coffin, Mehdi Brahmi, Hélène Vanacker, Lauriane Eberst, Olivier Trédan, Valéry Attignon, Daniel Pissaloux, Emilie Sohier, Philippe A. Cassier, Gwenaëlle Garin, David Pérol, Jean Yves Blay, Armelle Dufresne

Article2020

Utility of a general molecular screening program in patients with GU malignancies: The ProfiLER trial experience.

Armelle Vinceneux, Guillaume Moriceau, Marianne Lorcet, Mélodie Carbonnaux, Philippe A. Cassier, C. Terret, Christian Baudet, Valéry Attignon, Daniel Pissaloux, Sylvie Chabaud, Qing Wang, David Pérol, Olivier Trédan, Jean Yves Blay, Sylvie Négrier, Helen Jane Boyle, Aude Fléchon

Editorial Material2012

Biospecimen banking: The pathway to personalized medicine for patients with cancer

Richard A Scolyer, John F. Thompson

Article2025

Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial

Olivier Trédan, Damien Pouessel, Nicolas Penel, Sylvie Chabaud, Carlos Gomez‐Roca, Jean-Pierre Delord, Diane Pannier, Mehdi Brahmi, Michel Fabbro, Marie-Eve Garcia, Delphine Larrieu‐Ciron, Isabelle Ray‐Coquard, Marie Viala, Antoîne Italiano, Diégo Tosi, Philippe A. Cassier, Armelle Dufresne, Valéry Attignon, Sandrine Boyault, Isabelle Treilleux, Alain Viari, David Pérol, Jean Yves Blay

Article2023

Large versus limited molecular profiling panel screening program in patients with metastatic sarcoma: An exploratory subgroup analysis from the ProfiLER 02 trial.

Mehdi Brahmi, Olivier Trédan, Nicolas Penel, Christine Chevreau, Christophe Perrin, Nelly Firmin, Emmanuelle Bompas, François Bertucci, Valéry Attignon, Pierre Saintigny, Isabelle Treilleux, Sylvie Chabaud, Gwenaëlle Garin, David Pérol, Jean Yves Blay, Armelle Dufresne